BioCentury
ARTICLE | Company News

Aptiv Solutions, ICON deal

April 7, 2014 7:00 AM UTC

ICON will acquire fellow CRO Aptiv Solutions for $143.5 million in cash. Aptiv Solutions designs and executes adaptive clinical trials for pharmaceutical and biotech customers. ICON said that the acqu...